The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China

SciClone to Promote Potential Hospital Market Leaders in China, ANGIOMAX® (bivalirudin) and CLEVIPREX® (clevidipine) PARSIPPANY, N.J. & FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--The Medicines Company (MDCO), a global biopharma... Biopharmaceuticals, LicensingThe Medicines Company, SciClone Pharmaceuticals, ANGIOMAX, CLEVIPREX
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news